Top-News

Bioage Labs Aktie News

Aktie
WKN:  A40D7P ISIN:  US09077V1008 US-Symbol:  BIOA Branche:  Pharmazeutika Land:  USA
12,98 $
+0,23 $
+1,80%
11,050 € 20:53:26 Uhr
Depot/Watchlist
Marktkapitalisierung *
371,93 Mio. €
Streubesitz
27,06%
KGV
-2,92
Index-Zuordnung
-

Bioage Labs News

20.01.25 - PR Newswire
The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire
18.01.25 - PR Newswire
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit PR Newswire
17.01.25 - PR Newswire
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire
16.01.25 - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA
BioAge Labs, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire
15.01.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
15.01.25 - PR Newswire
Class Action Announcement for BioAge Labs, Inc. (BIOA): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc.
Class Action Announcement for BioAge Labs, Inc. (BIOA): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioAge ...
14.01.25 - PR Newswire
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class Action - BIOA
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class Action - BIOA PR Newswire
11.01.25 - PR Newswire
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
10.01.25 - PR Newswire
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...
10.01.25 - PR Newswire
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire
10.01.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
09.01.25 - PR Newswire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit PR Newswire
09.01.25 - PR Newswire
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial- Hagens Berman
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-​Loss Drug Trial- Hagens Berman PR Newswire
09.01.25 - PR Newswire
Class Action Filed Against BioAge Labs, Inc. (BIOA) - March 10, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against BioAge Labs, Inc. (BIOA) - March 10, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
08.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioAge Labs, Inc. - BIOA
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioAge Labs, Inc. - BIOA PR Newswire
08.01.25 - PR Newswire
BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action
BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the ...
08.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA PR Newswire
08.01.25 - PR Newswire
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
03.01.25 - PR Newswire
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman PR Newswire
02.01.25 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. - BIOA PR Newswire

Newssuche

Videos

newspaper
09:50 Uhr +1,10%
Technical Trading: Neues Allzeithoch im Visier
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »